FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/01/048840 [Registered on: 09/01/2023] Trial Registered Prospectively
Last Modified On: 20/12/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To study the effect of Dadimadi Churna in the management of Peenasa 
Scientific Title of Study   A single arm clinical study to evaluate the efficacy of Dadimadi Churna in the management of Peenasa (Chronic Rhinitis) in children 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Saurabh Raosaheb Mhaske  
Designation  MD Scholar 
Affiliation  Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018 
Address  OPD NO 1 Kaumarbhritya Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9011286293  
Fax    
Email  mhaskesaurabh33@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravindra Rajpal 
Designation  Associate Professor 
Affiliation  Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018 
Address  OPD NO 1 Kaumarbhritya Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9922037201  
Fax    
Email  ravirajpal24@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ravindra Rajpal 
Designation  Associate Professor 
Affiliation  Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018 
Address  OPD NO 1 Kaumarbhritya Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9922037201  
Fax    
Email  ravirajpal24@gmail.com  
 
Source of Monetary or Material Support  
Dr.D.Y.Patil college of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018 
 
Primary Sponsor  
Name  Dr. Saurabh Mhaske  
Address  OPD NO 1 Kaumarbhritya Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Saurabh Mhaske   Dr.D.Y.Patil college of Ayurved and Research Centre,Sant Tukaram Nagar,pimpri,pune 411018  OPD No 1 Kaumarbhritya Dr.D.Y.PATIL College Of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune411018
Pune
MAHARASHTRA 
9011286293

mhaskesaurabh33@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC COMMITE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J069||Acute upper respiratory infection,unspecified. Ayurveda Condition: PRATISYAYAH/PINASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Dadimadi Churna , Reference: Baltantra, Route: Oral, Dosage Form: Churna/ Powder, Dose: 0.92(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: - Honey), Additional Information: -
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  The patients having at least 2 – 3 symptoms of Peenasa are as follows-
Nasastrava,Frequency of Kshavathu ,Nasavarodha, Nasakandu and Shirashoola.The patients of age from 3 year to 12 years.
The patients who separents are ready to participate in the clinical trial by giving informed written consent. 
 
ExclusionCriteria 
Details  Patients and his/her parents/guardian not willing for trial.Patients having life threatening illness and who is bedridden.Patient who need surgical and other intervention.Patients presenting with symptoms of Dushta Peenasa/ Pratishyaya and Raktaga.Patients suffering with other Nasal diseases like Nasal Polyps, Nasal Septum
Patients associated with Nasal Malignancy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in the symptoms of Peenasa  7 day study , 0th,3rd ,7th day 
 
Secondary Outcome  
Outcome  TimePoints 
To observe the adverse effect of Dadimadi Churna  7 day study , 0th,3rd ,7th day 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single arm clinical study in which medicine Dadimadi Churna will be provided to 36 patients showing classical sign and symptoms of Peenasa for releving symptoms . The study will be between the age group of 3 years to 12 years . Dose will be calculated by youngs formula ,follow up on 3rd day and 7th day  
Close